NCI-2011-02549

Phase II Study of Akt Inhibitor MK2206 in Patients With Advanced Hepatocellular Carcinoma Who Have Failed or Are Intolerant of One Prior Line of Antiangiogenic Therapy


Penn State Milton S Hershey Medical Center
500 University Drive
Hershey, PA 17033
717-531-6012

University of Maryland/Greenebaum Cancer Center
22 SOUTH GREENE STREET
Baltimore, MD 21201
410-328-1229

University of Pittsburgh Cancer Institute (UPCI)
Hillman Cancer Center
5150 Centre Avenue
Pittsburgh, PA 15232
412-864-3681

Ohio State University Medical Center
410 West Tenth Avenue
Columbus, OH 43210

University of Michigan Health System-Cancer Center
1500 E. Medical Center Dr
C-365 Med Inn Building
Ann Arbor, MI 48109
734-936-2740

Fort Wayne Medical Oncology and Hematology Inc - State Boulevard
11143 Parkview Plaza Drive
Suite 100
Fort Wayne, IN 46815
260-484-8830

Northern Indiana Cancer Research Consortium
3975 William Richardson Drive
South Bend, IN 46628
574-234-5123

Oncology Care Associates, PLLC
Saint Joseph, MI 49085
269-985-0029

University of Chicago
5841 South Maryland Avenue
Chicago, IL 60637
773-834-7424

Ingalls Memorial Hospital
One Ingalls Dr
W740
Harvey, IL 60426

Loyola University Medical Center
2160 South First Avenue
Maywood, IL 60153
708-327-3229

Froedtert Hospital
Froedtert Hospital
9200 W Wisconsin Ave
Milwaukee, WI 53201
414-937-6416

Joliet Oncology-Hematology Associates Limited
2614 W. Jefferson Street
Joliet, IL 60435

Decatur Memorial Hospital
2300 North Edwards Street
Decatur, IL 62526

Southern Illinois University School of Medicine
801 North Rutledge
Springfield, IL 62702

Mercy Hospital Saint Louis
607 S. New Ballas Road
Suite 2415
St. Louis, MO 63141
314-251-7883

City of Hope
1500 E Duarte Rd
Medical Office Bldg, 4th Floor
Duarte, CA 91010
626-256-4673

University of California at Davis Cancer Center
4501 X Street
Sacramento, CA 95817
916-734-3643